ArticleAssessment of Glucagon-like Peptide-1 Receptor Agonists in Veterans TakingBasal/Bolus Insulin RegimensAuthor:Lindsey C. Healey, PharmD, CDCES, BC-ADMPublish date: September 26, 2022This study assessed the long-term efficacy of GLP-1 RAs as add-on therapy to basal/bolus insulin regimens over 18 months at a single VA medical cen...Read More
